Skip to Main Content

Author Details

Richard D Boyce
University of Pittsburgh
2005
80
17
PMIDPaper TitleJournal TitlePublished Year
37243500Reply: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS).Ann Pharmacother2024
37243500Reply: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS).Ann Pharmacother2024
36861661An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021.Clin Transl Sci2023
37574018Qualitative analysis of healthcare provider perspectives to evaluating beta-lactam allergies.J Hosp Infect2023
36522578Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management.Drug Saf2023
37086959Causal feature selection using a knowledge graph combining structured knowledge from the biomedical literature and ontologies: A use case studying depression as a risk factor for Alzheimer's disease.J Biomed Inform2023
37332887Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study.Ther Adv Drug Saf2023
36815661Early prediction of Alzheimer's disease and related dementias using real-world electronic health records.Alzheimers Dement2023
36933632Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug Interactions.J Biomed Inform2023
36688283Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS).Ann Pharmacother2023
36861661An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021.Clin Transl Sci2023
37574018Qualitative analysis of healthcare provider perspectives to evaluating beta-lactam allergies.J Hosp Infect2023
37086959Causal feature selection using a knowledge graph combining structured knowledge from the biomedical literature and ontologies: A use case studying depression as a risk factor for Alzheimer's disease.J Biomed Inform2023
37332887Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study.Ther Adv Drug Saf2023
36522578Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management.Drug Saf2023
36815661Early prediction of Alzheimer's disease and related dementias using real-world electronic health records.Alzheimers Dement2023
36688283Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS).Ann Pharmacother2023
36933632Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug Interactions.J Biomed Inform2023
35136935Improving the specificity of drug-drug interaction alerts: Can it be done?Am J Health Syst Pharm2022
35834155A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS).Drug Saf2022
35581469Machine learning based algorithms to impute PaO<sub>2</sub> from SpO<sub>2</sub> values and development of an online calculator.Sci Rep2022
36223037Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)".Drug Saf2022
35818288Falls prediction using the nursing home minimum dataset.J Am Med Inform Assoc2022
35673040Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review.Stud Health Technol Inform2022
35358893Coordinated use of Health Level 7 standards to support clinical decision support: Case study with shared decision making and drug-drug interactions.Int J Med Inform2022
35665910QTc Prolongation with the Use of Hydroxychloroquine and Concomitant Arrhythmogenic Medications: A Retrospective Study Using Electronic Health Records Data.Drugs Real World Outcomes2022
36910569Getting to YES: The Evolution of the University of Pittsburgh Medical Center Hillman Cancer Center Youth Enjoy Science (YES) Academy.J STEM Outreach2022
36581417Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case-control study in the National COVID Cohort Collaborative (N3C).BMJ Open2022
33599896A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.Cardiovasc Drugs Ther2022
35136935Improving the specificity of drug-drug interaction alerts: Can it be done?Am J Health Syst Pharm2022
35581469Machine learning based algorithms to impute PaO<sub>2</sub> from SpO<sub>2</sub> values and development of an online calculator.Sci Rep2022
35673040Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review.Stud Health Technol Inform2022
35834155A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS).Drug Saf2022
35665910QTc Prolongation with the Use of Hydroxychloroquine and Concomitant Arrhythmogenic Medications: A Retrospective Study Using Electronic Health Records Data.Drugs Real World Outcomes2022
35818288Falls prediction using the nursing home minimum dataset.J Am Med Inform Assoc2022
35358893Coordinated use of Health Level 7 standards to support clinical decision support: Case study with shared decision making and drug-drug interactions.Int J Med Inform2022
36581417Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case-control study in the National COVID Cohort Collaborative (N3C).BMJ Open2022
36910569Getting to YES: The Evolution of the University of Pittsburgh Medical Center Hillman Cancer Center Youth Enjoy Science (YES) Academy.J STEM Outreach2022
36223037Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)".Drug Saf2022
33599896A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.Cardiovasc Drugs Ther2022
33174626Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail.Clin Pharmacol Ther2021
33644415Fall Risk-Increasing Drugs, Polypharmacy, and Falls Among Low-Income Community-Dwelling Older Adults.Innov Aging2021
34103383Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database.Respir Care2021
33936429Automatically classifying the evidence type of drug-drug interaction research papers as a step toward computer supported evidence curation.AMIA Annu Symp Proc2021
33763631Designing and evaluating contextualized drug-drug interaction algorithms.JAMIA Open2021
33762928A Minimal Information Model for Potential Drug-Drug Interactions.Front Pharmacol2021
33716168Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance.J Biomed Inform2021
33174626Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail.Clin Pharmacol Ther2021
34698649A Shared Decision-making Tool for Drug Interactions Between Warfarin and Nonsteroidal Anti-inflammatory Drugs: Design and Usability Study.JMIR Hum Factors2021
33716168Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance.J Biomed Inform2021
  • 1 - 50 of 160

Recommended Authors

James R Rogers
Columbia University
Career Start Year 2015
Number of shared co-authors 3
Yue Yu
Health Sciences Mayo Clinic
Career Start Year 2012
Number of shared co-authors 2
Rui Zhang
University of Minnesota
Career Start Year 2011
Number of shared co-authors 2
Allison B McCoy
Vanderbilt University Medical Center
Career Start Year 2010
Number of shared co-authors 3
Joshua C Smith
Vanderbilt University Medical Center
Career Start Year 2010
Number of shared co-authors 3
Krystl Haerian
George Washington University
Career Start Year 2009
Number of shared co-authors 0
Paul Avillach
Harvard Medical School
Career Start Year 2007
Number of shared co-authors 7
Shobha Phansalkar
Wolters Kluwer Health-Clinical Solutions-Medical Informatics
Career Start Year 2006
Number of shared co-authors 1
Matvey B Palchuk
Harvard Medical School
Career Start Year 2005
Number of shared co-authors 1
Jyotishman Pathak
Cornell University
Career Start Year 2005
Number of shared co-authors 7
Joshua J Gagne
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 2
Joseph M Tonning
U.S. Public Health Service/U.S. FDA retired
Career Start Year 2004
Number of shared co-authors 1
Nigam H Shah
Stanford University
Career Start Year 2002
Number of shared co-authors 17
Terrence J Adam
University of Minnesota, Institute for Health Informatics.
Career Start Year 2002
Number of shared co-authors 1
Chunhua Weng
Columbia University Irving Medical Center
Career Start Year 2002
Number of shared co-authors 13
Grace M Kuo
Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center
Career Start Year 2001
Number of shared co-authors 1
Rebecca N Jerome
12328Vanderbilt University Medical Center
Career Start Year 2001
Number of shared co-authors 0
Joshua C Denny
Vanderbilt University
Career Start Year 2000
Number of shared co-authors 15
Pedro J Caraballo
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 2
Diane L Seger
Clinical and Quality Analysis
Career Start Year 1998
Number of shared co-authors 1
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 3
John F Hurdle
University of Utah
Career Start Year 1996
Number of shared co-authors 1
Alexander Turchin
Brigham and Women's Hospital
Career Start Year 1996
Number of shared co-authors 2
Peggy L Peissig
Center for Precision Medicine Research, Marshfield Clinic Research Institute
Career Start Year 1996
Number of shared co-authors 6
Gerald J Dal Pan
Center for Drug Evaluation and Research
Career Start Year 1989
Number of shared co-authors 0
William L Galanter
University of Illinois Chicago
Career Start Year 1989
Number of shared co-authors 1
George Hripcsak
Columbia University
Career Start Year 1988
Number of shared co-authors 20
Ida Sim
University of California San Francisco
Career Start Year 1985
Number of shared co-authors 4
Peter L Elkin
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year 1985
Number of shared co-authors 3
Dennis W Raisch
The University of New Mexico
Career Start Year 1977
Number of shared co-authors 0

Collaborators

Sandra L Kane-Gill
Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh
Co-authored papers 11
Steven M Handler
University of Pittsburgh
Co-authored papers 10
Mathias Brochhausen
College of Medicine, University of Arkansas for Medical Sciences
Co-authored papers 9
Harry Hochheiser
University of Pittsburgh
Co-authored papers 9
Matthias Samwald
Institute of Artificial Intelligence, Medical University of Vienna
Co-authored papers 8
Michel Dumontier
Institute of Data Science, Maastricht University
Co-authored papers 6
Vignesh Subbian
College of Engineering, University of Arizona
Co-authored papers 6
Mary F Paine
Washington State University
Co-authored papers 5
Robert R Freimuth
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 5
Patrick B Ryan
Columbia University Irving Medical Center
Co-authored papers 4
Guilherme Del Fiol
University of Utah
Co-authored papers 3
Qian Zhu
University of Maryland Baltimore County
Co-authored papers 3
Kensaku Kawamoto
University of Utah, USA University of Utah Health
Co-authored papers 3
Martijn J Schuemie
University of California los angeles
Co-authored papers 3
Jon Duke
Georgia Tech Research Institute, Georgia Tech College of Computing
Co-authored papers 2
Vojtech Huser
Lister Hill National Center for Biomedical Communication
Co-authored papers 2
Erica A Voss
Erasmus University Medical Center
Co-authored papers 2
Majid Rastegar-Mojarad
Mayo Clinic
Co-authored papers 2
Nicholas P Tatonetti
Columbia Universtiy College of Physicians and Surgeons
Co-authored papers 2
Joanne S Luciano
Web Science Research Center, Rensselaer Polytechnic Institute
Co-authored papers 2
Tiffany J Callahan
Columbia University
Co-authored papers 2
William R Hogan
College of Medicine, University of Florida
Co-authored papers 2
Frank DeFalco
Janssen Pharmaceutical Research & Development
Co-authored papers 1
Mehdi Nouraie
Co-authored papers 1
Michael J Fine
University of Pittsburgh School of Medicine
Co-authored papers 1
Rave Harpaz
Co-authored papers 1
Paul T Kocis
Department of Pharmacy, Penn State Milton S. Hershey Medical Center
Co-authored papers 1
George Caleb Alexander
Institute of General Practice and Family Medicine, University Hospital
Co-authored papers 1
Ritu Khare
Co-authored papers 1
Abraham G Hartzema
Co-authored papers 1
Release 1.2